Creating diseases to understand what prevents them: Genetic analysis of inflammation in the gastrointestinal tract

Current Opinion in Immunology

Volumn 24, Issue 6, 2012, Pages 678-685

  Brandl, Katharina ^a   Beutler, Bruce ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; ANTIBIOTIC AGENT; AQUAPORIN 3; DEXTRAN SULFATE; EPIDERMAL GROWTH FACTOR; EPIREGULIN; MUCIN 2; TOLL LIKE RECEPTOR;

CROHN DISEASE; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INTESTINE FLORA; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PENETRANCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UNFOLDED PROTEIN RESPONSE; YPT1P INTERACTING PROTEIN FAMILY MEMBER 6 GENE;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HUMANS;

EID: 84869863647     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.10.005     Document Type: Review

References (50)

1. Podolsky DK Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
2. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
3. Yamamoto-Furusho J.K., Podolsky D.K. Innate immunity in inflammatory bowel disease. World J Gastroenterol 2007, 13:5577-5580.
4. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:390-407.
5. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
6. Fukata M., Michelsen K.S., Eri R., Thomas L.S., Hu B., Lukasek K., Nast C.C., Lechago J., Xu R., Naiki Y., et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 2005, 288:G1055-G1065.
7. Brown S.L., Riehl T.E., Walker M.R., Geske M.J., Doherty J.M., Stenson W.F., Stappenbeck T.S. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 2007, 117:258-269.
8. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
9. Iqbal N., Oliver J.R., Wagner F.H., Lazenby A.S., Elson C.O., Weaver C.T. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J Exp Med 2002, 195:71-84.
10. Hugot J.P., Zouali H., Lesage S. Lessons to be learned from the NOD2 gene in Crohn's disease. Eur J Gastroenterol Hepatol 2003, 15:593-597.
11. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2000, 2:326-332.
12. Heazlewood C.K., Cook M.C., Eri R., Price G.R., Tauro S.B., Taupin D., Thornton D.J., Png C.W., Crockford T.L., Cornall R.J., et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008, 5:e54.
13. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078.
14. Ordas I., Mould D.R., Feagan B.G., Sandborn W.J. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther 2012, 91:635-646.
15. Salzman N.H., Bevins C.L. Negative interactions with the microbiota: IBD. Adv Exp Med Biol 2008, 635:67-78.
16. Rakoff-Nahoum S., Hao L., Medzhitov R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006, 25:319-329.
17. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., Punit S., Karlsson M., Bry L., Glickman J.N., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
18. Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., Glickman J.N., Glimcher L.H. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
19. Bjornsson S., Johannsson J.H. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000, 12:31-38.
20. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004, 18:481-496.
21. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998, 16:351-355.
22. Binder V., Orholm M. Familial occurrence and inheritance studies in inflammatory bowel disease. Neth J Med 1996, 48:53-56.
23. Duerr R.H. Update on the genetics of inflammatory bowel disease. J Clin Gastroenterol 2003, 37:358-367.
24. Spehlmann M.E., Begun A.Z., Burghardt J., Lepage P., Raedler A., Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008, 14:968-976.
25. Halfvarson J., Jess T., Bodin L., Jarnerot G., Munkholm P., Binder V., Tysk C. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis 2007, 13:1536-1544.
26. Halme L., Paavola-Sakki P., Turunen U., Lappalainen M., Farkkila M., Kontula K. Family and twin studies in inflammatory bowel disease. World J Gastroenterol 2006, 12:3668-3672.
27. Glocker E.O., Kotlarz D., Klein C., Shah N., Grimbacher B. IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci 2011, 1246:102-107.
28. Budarf M.L., Labbe C., David G., Rioux J.D. GWA studies: rewriting the story of IBD. Trends Genet 2009, 25:137-146.
29. Nachman M.W., Crowell S.L. Estimate of the mutation rate per nucleotide in humans. Genetics 2000, 156:297-304.
30. Smirnova I., Mann N., Dols A., Derkx H.H., Hibberd M.L., Levin M., Beutler B. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A 2003, 100:6075-6080.
31. Ji W., Foo J.N., O'Roak B.J., Zhao H., Larson M.G., Simon D.B., Newton-Cheh C., State M.W., Levy D., Lifton R.P. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008, 40:592-599.
32. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004, 305:869-872.
33. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
34. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
35. Kaser A., Lee A.H., Franke A., Glickman J.N., Zeissig S., Tilg H., Nieuwenhuis E.E., Higgins D.E., Schreiber S., Glimcher L.H., et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008, 134:743-756.
36. Brandl K., Rutschmann S., Li X., Du X., Xiao N., Schnabl B., Brenner D.A., Beutler B. Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response. Proc Natl Acad Sci U S A 2009, 106:3300-3305.
37. Thiagarajah J.R., Zhao D., Verkman A.S. Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis. Gut 2007, 56:1529-1535.
38. Brandl K., Sun L., Neppl C., Siggs O.M., Le Gall S.M., Tomisato W., Li X., Du X., Maennel D.N., Blobel C.P., et al. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc Natl Acad Sci U S A 2010, 107:19967-19972.
39. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
40. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
41. Vijay-Kumar M., Wu H., Aitken J., Kolachala V.L., Neish A.S., Sitaraman S.V., Gewirtz A.T. Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 2007, 13:856-864.
42. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., et al. An essential role for ectodomain shedding in mammalian development. Science 1998, 282:1281-1284.
43. Lee D., Pearsall R.S., Das S., Dey S.K., Godfrey V.L., Threadgill D.W. Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage. Mol Cell Biol 2004, 24:8907-8916.
44. Troyer K.L., Luetteke N.C., Saxon M.L., Qiu T.H., Xian C.J., Lee D.C. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. Gastroenterology 2001, 121:68-78.
45. Brandl K., Tomisato W., Li X., Neppl C., Pirie E., Falk W., Xia Y., Moresco E.M., Baccala R., Theofilopoulos A.N., et al. Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice. Proc Natl Acad Sci U S A 2012.
46. Tang B.L., Ong Y.S., Huang B., Wei S., Wong E.T., Qi R., Horstmann H., Hong W. A membrane protein enriched in endoplasmic reticulum exit sites interacts with COPII. J Biol Chem 2001, 276:40008-40017.
47. Sui H., Han B.G., Lee J.K., Walian P., Jap B.K. Structural basis of water-specific transport through the AQP1 water channel. Nature 2001, 414:872-878.
48. Liu L., Botos I., Wang Y., Leonard J.N., Shiloach J., Segal D.M., Davies D.R. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008, 320:379-381.
49. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000, 408:111-115.
50. Arnold CN, Barnes MJ, Berger M, Blasius AL, Brandl K, Croker B, Crozat K, Du X, Eidenschenk C, Georgel P, et al.: ENU, mutations, and phenovariance in mice: inferences from 587 mutations. BMC Research Notes, in press.